April 28, 2022 China reports first human infection of H3N8 bird flu strain China's National Health Commission said that it recorded its first human infection with the H3N8 strain of avian influenza.
April 27, 2022 Shanghai tests to loosen COVID lockdown Shanghai officials said Wednesday that they would begin COVID-19 testing over the coming days to determine which neighborhoods were considered lower risk.
April 26, 2022 Beijing conducts mass COVID testing, enforces lockdowns Beijing residents lined up for throat swabs as workers put up fencing and police restricted who could leave a locked-down area on Tuesday after health officials said that 22 new COVID-19 cases were found over the course of the last 24 hours.
April 23, 2022 COVID cases in Beijing lead officials to suspend classes, conduct mass testing China's capital city of Beijing is on alert after 10 middle school students tested positive for the coronavirus.
April 22, 2022 Shanghai pledges to improve food supplies, ease virus restrictions Shanghai officials pledged Friday to ease anti-virus regulations on truck drivers that are reportedly hampering food supplies and trade.
April 21, 2022 Tick bites on the rise: How to stay safe as you head outdoors Tick bites are on the rise in the U.S. with the Centers for Disease Control and Prevention (CDC) reporting that the majority of cases typically occur in the warmer months.
April 21, 2022 Maine resident dies from rare tick virus A person in eastern Maine has died from a rare virus spread by an infected tick.
April 15, 2022 East Coast COVID-19 cases on the rise As sub-variants of omicron continue to spread in the U.S. and abroad, infections are rising in East Coast states and cities.
April 15, 2022 Chinese cities restrict access as COVID-19 infections rise; South Korea moves to lift most regulations While Shanghai is easing COVID-19 rules for some of its 25 million residents, anti-virus controls in the country are spreading as infections rise.
April 14, 2022 Pfizer, BioNTech will ask FDA to authorize COVID booster for healthy kids ages 5-11 Pfizer and BioNTech said Tuesday that they would ask the Food and Drug Administration (FDA) to authorize a booster dose of their coronavirus vaccine for emergency use in healthy kids ages 5 to 11.